This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

LSE, Refinitiv warned of risks in Singapore if they complete deal before review is done

( January 20, 2021, 07:26 GMT | Official Statement) -- MLex Summary: The London Stock Exchange, or LSE, and financial markets data-provider Refinitiv Holdings may complete their merger without waiting for Singaporean antitrust clearance, the regulator said, but face the risk of being subjected to remedies, financial penalties or even an order for dissolution. The warning from the Competition and Consumer Commission of Singapore comes in response to LSE’s announcement of its intention to complete the deal by Jan. 29, 2021. The regulator is still reviewing the parties' proposed commitments to address the concerns it raised last year. The commission's statement is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents